Topic hub
Medications
Drug-specific guidance, comparisons, approvals, and maintenance decisions.
Evidence-based explainers for semaglutide, tirzepatide, Foundayo, Wegovy, Ozempic, Mounjaro, and medication-specific decision points.
In this hub
8 guides
Each article below appears once in the approved primary IA.
Every article in Medications
Browse the full category
Start here Medications
Semaglutide: The Complete Guide to Ozempic, Wegovy, and Rybelsus
An evidence-based guide to semaglutide — how it works in the brain and body, what separates Ozempic from Wegovy from Rybelsus, the main clinical trial results, and what the FDA says about compounded versions.
Semaglutide: The Complete Guide to Ozempic, Wegovy, and Rybelsus →
10 sources Medications
Tirzepatide vs. Semaglutide: What the Clinical Evidence Actually Shows
A head-to-head comparison of tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) drawing on SURPASS-2, SURMOUNT, and STEP trial data — including the neuroscience behind why dual GIP/GLP-1 agonism may produce greater metabolic effects.
Tirzepatide vs. Semaglutide: What the Clinical Evidence Actually Shows → 13 sources Medications
Ozempic vs. Mounjaro: Which One Is Right for You?
A research-first comparison of Ozempic and Mounjaro for people deciding between semaglutide and tirzepatide, including head-to-head trial data, side effect numbers, dosing differences, and the cost question most comparison pages blur.
Ozempic vs. Mounjaro: Which One Is Right for You? → 9 sources Medications
FDA Approves Foundayo: What GLP-1 Patients Need to Know
Foundayo, the new brand name for orforglipron, is now FDA-approved for chronic weight management. This guide covers what was approved, how the once-daily GLP-1 pill works, what the clinical trial numbers actually show, when it ships, and where the biggest unknowns still are.
FDA Approves Foundayo: What GLP-1 Patients Need to Know →
10 sources Medications
Foundayo Guide: Dosing, Cost, Side Effects, and How It Compares in 2026
An evidence-based guide to Foundayo (orforglipron) covering who it is for, how the daily pill is taken, what the current trial data show, what it costs now, and how it compares with Wegovy tablets and weekly injectable GLP-1 options.
Foundayo Guide: Dosing, Cost, Side Effects, and How It Compares in 2026 → 10 sources Medications
Foundayo vs. Wegovy Pill: Which Oral GLP-1 Is Better in 2026?
An evidence-based comparison of Foundayo and Wegovy pill covering how each oral GLP-1 is taken, what the current weight-loss evidence actually shows, side-effect tradeoffs, and where cost and access differ as of April 14, 2026.
Foundayo vs. Wegovy Pill: Which Oral GLP-1 Is Better in 2026? → 7 sources Medications
Wegovy 7.2 mg: Who It's For, How It Compares, and What to Expect
Wegovy now has a 7.2 mg once-weekly option for some adults who need more weight loss after 2.4 mg. This guide explains who can escalate, how the higher dose compares with older Wegovy dosing, what the trial results actually showed, which side effects may rise, and what to ask a clinician before moving up.
Wegovy 7.2 mg: Who It's For, How It Compares, and What to Expect → 10 sources Medications
Stopping GLP-1 Medications: Weight Regain Data, Tapering, and What to Plan For
An evidence-based guide to what usually happens after stopping semaglutide or tirzepatide, including the best withdrawal data we have on weight regain, blood sugar, blood pressure, tapering, and maintenance planning.
Stopping GLP-1 Medications: Weight Regain Data, Tapering, and What to Plan For →